Interaction between BDNF and Serotonin: Role in Mood Disorders
The DOI matches its Crossref record; 132 of the 133 references it cites were found in a registry or an index.
Abstract
Brain-derived neurotrophic factor (BDNF) and serotonin (5-hydroxytryptamine, 5-HT) are two seemingly distinct signaling systems that play regulatory roles in many neuronal functions including survival, neurogenesis, and synaptic plasticity. A common feature of the two systems is their ability to regulate the development and plasticity of neural circuits involved in mood disorders such as depression and anxiety. BDNF promotes the survival and differentiation of 5-HT neurons. Conversely, administration of antidepressant selective serotonin reuptake inhibitors (SSRIs) enhances BDNF gene expression. There is also evidence for synergism between the two systems in affective behaviors and genetic epitasis between BDNF and the serotonin transporter genes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“BDNF+/− mice show less dendritic branching as well as dendritic retraction and simplification in CA381 and DG80 and dysregulation of BDNF/TrkB pathways has been reported in MDD and animal models of depression78, 169-171.”
From Dysregulation of adult hippocampal neuroplasticity in major depression: Pathogenesis and therapeutic implications (2022) · cites this paper as [169]
Citations
Cites
Lesch, K.-P., Bengel, D., Heils, A., Sabol, S. Z., Greenberg, B. D., Petri, S., Benjamin, J., Müller, C. R., Hamer, D. H., & Murphy, D. L. (1996) · Science · doi:10.1126/science.274.5292.1527 · Cited by 5,162 · cited 4×
“Analysis of the promoter region of 5-HTT has revealed a polymorphism that results in allelic variation in functional 5-HTT expression (”
BackgroundInfluentialNeurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394 · cited 2×
“…survival of peripheral neurons, BDNF is now recognized as a plethoric factor able to regulate a wide repertoire of functions, including neuronal survival, migration, phenotypic differentiation, axonal and dendritic growth, and synapse formation (Huang and Reichardt, 2001; Lewin and Barde, 1996).”
BackgroundRequirement of hippocampal neurogenesis for the behavioral effects of antidepressants
Santarelli, L., Saxe, M., Gross, C., Surget, A., Battaglia, F., Dulawa, S., Weisstaub, N., Lee, J., Duman, R., Arancio, O., et al. (2003) · Science · doi:10.1126/science.1083328 · Cited by 4,321 · cited 2×
“Like BDNF, alterations in 5-HT signaling have demonstrable effects on synaptic plasticity and adult neurogenesis in the hippocampus (Brezun and Daszuta, 1999; Gould, 1999; Santarelli et al, 2003; Djavadian, 2004).”
BackgroundEgan, M. F., Kojima, M., Callicott, J. H., Goldberg, T. E., Kolachana, B. S., Bertolino, A., Zaitsev, E., Gold, B., Goldman, D., Dean, M., et al. (2003) · Cell · doi:10.1016/s0092-8674(03)00035-7 · Cited by 3,888 · cited 2×
“Human subjects carrying the Val66Met SNP exhibit deficits in short-term episodic memory and show abnormal hippocampal activation (”
BackgroundSelf-citationA Neurotrophic Model for Stress-Related Mood Disorders
Duman, R. S., & Monteggia, L. M. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.02.013 · Cited by 3,375 · cited 7×
“…76 .............................................................................................................................................. Neuropsychopharmacology REVIEWS REVIEW has lagged (Duman and Monteggia, 2006).”
BackgroundInfluentialNestler, E. J., Barrot, M., DiLeone, R. J., Eisch, A. J., Gold, S. J., & Monteggia, L. M. (2002) · Neuron · doi:10.1016/s0896-6273(02)00653-0 · Cited by 3,217
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus
Malberg, J. E., Eisch, A. J., Nestler, E. J., & Duman, R. S. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-09104.2000 · Cited by 3,111 · cited 1×
“Importantly, antidepressants and the mood stabilizer lithium have been shown to elicit an increase in hippocampal neurogenesis (Chen et al, 2000; Malberg et al, 2000).”
BackgroundTrk Receptors: Roles in Neuronal Signal Transduction
Huang, E. J., & Reichardt, L. F. (2003) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.72.121801.161629 · Cited by 2,537 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundNeurotrophins and their receptors: A convergence point for many signalling pathways
Chao, M. V. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1078 · Cited by 2,298 · cited 2×
“Binding of mature BDNF (mBDNF) to TrkB triggers tyrosine phosphorylation in its cytoplasmic domain, leading to activation of at least three signaling pathways: MEK–MAPK, phosphatidylinositol-3-kinase (PI3-K) and phospholipase C-g (PLC-g) (Kaplan and Miller, 2000; Chao, 2003; Huang and Reichardt, 2003).”
BackgroundCREB: A Stimulus-Induced Transcription Factor Activated by A Diverse Array of Extracellular Signals
Shaywitz, A. J., & Greenberg, M. E. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.821 · Cited by 2,134 · cited 2×
“Extensive studies have shown that CREB can be activated via phosphorylation at serine 133 by three signaling pathways: cAMP-PKA, Ca2 + -CaMKIV, and MAPK pathways (Shaywitz and Greenberg, 1999).”
Background
Cited by
Items 201–300 of 906
Rosa, S. G., Quines, C. B., Stangherlin, E. C., & Nogueira, C. W. (2015) · Physiology & Behavior · doi:10.1016/j.physbeh.2015.11.038 · Cited by 63
Morshedi, M., Valenlia, K. B., Hosseinifard, E. S., Shahabi, P., Abbasi, M. M., Ghorbani, M., Barzegari, A., Sadigh-Eteghad, S., & Saghafi-Asl, M. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.03.022 · Cited by 52
Millard, S. J., Weston-Green, K., & Newell, K. A. (2020) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2020.109908 · Cited by 62
Pudell, C., Vicente, B. A., Delattre, A. M., Carabelli, B., Mori, M. A., Suchecki, D., Machado, R. B., Zanata, S. M., Visentainer, J. V., de Oliveira Santos, O., et al. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12406 · Cited by 52
“Considering the present results, we suggest that FO supplementation induced, primarily, the increase in hippocampal expression of BDNF, which mediates cell survival, growth, and plasticity (Martinowich & Lu, 2008).”
BackgroundGoswami, D. B., May, W. L., Stockmeier, C. A., & Austin, M. C. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06462.x · Cited by 61
“…(TrkB) and estrogen by its action on estrogen receptors (ERa and ERb) have been reported to exert profound effects on serotonin DR neurons and serotonin neurotransmission (Joffe and Cohen 1998; Mattson et al. 2004; Shively and Bethea 2004; Lasiuk and Hegadoren 2007; Martinowich and Lu 2008).”
BackgroundMacrì, S., Laviola, G., Leussis, M. P., & Andersen, S. L. (2009) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2009.07.016 · Cited by 61
“Together, these data support the view that BDNF and serotonin interact in the etiology of affective disorders (Martinowich and Lu, 2008).”
ResultWin‐Shwe, T., Nway, N. C., Imai, M., Lwin, T., Mar, O., & Watanabe, H. (2018) · The Journal of Toxicological Sciences · doi:10.2131/jts.43.631 · Cited by 61
Henningsson, S., Borg, J., Lundberg, J., Bah, J., Lindström, M., Ryding, E., Jovanovic, H., Saijo, T., Inoue, M., Rosén, I., et al. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.04.009 · Cited by 61
Deltheil, T., Tanaka, K., Reperant, C., Hen, R., David, D. J., & Gardier, A. M. (2009) · International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709000017 · Cited by 54
Miquel-Rio, L., Alarcón-Arís, D., Torres‐López, M., Cóppola-Segovia, V., Pavia-Collado, R., Paz, V., Ruiz‐Bronchal, E., Campa, L., Casal, C., Montefeltro, A., et al. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-01842-z · Cited by 60
“Given the relevance of the 5-HT system for BDNF expression [61, 62, 75], the reduced 5-HT availability may drive the changes in hippocampal BDNF expression described in the AAV5 mouse model.”
BackgroundWysokiński, A. (2016) · Nordic Journal of Psychiatry · doi:10.3109/08039488.2015.1087592 · Cited by 60
“The role of BDNF in the development of mood disorders is best studied (3).”
BackgroundPeritore, A. F., Crupi, R., Scuto, M. C., Gugliandolo, E., Siracusa, R., Impellizzeri, D., Cordaro, M., D’Amico, R., Fusco, R., Paola, R. D., et al. (2020) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527319666200107094732 · Cited by 61
Oral contraceptives and the serotonin 4 receptor: a molecular brain imaging study in healthy women
Larsen, S. V., Köhler‐Forsberg, K., Dam, V. H., Poulsen, A. S., Svarer, C., Jensen, P. S., Knudsen, G. M., Fisher, P. M., Ozenne, B., & Frøkjær, V. G. (2020) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.13211 · Cited by 59
“Given the important role of the serotonergic system in MDD (23), our finding of lower 5-HT4R BPND among OC users represents a potential mechanism by which OC use can trigger depressive episodes (6, 7).”
BackgroundLeschik, J., Gentile, A., Cicek, C., Péron, S., Tevosian, M., Beer, A., Radyushkin, K., Bludau, A., Ebner, K., Neumann, I., et al. (2022) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2022.102333 · Cited by 58
“Changes in BDNF and 5-HT signaling have been described as key triggers of e.g. enhanced anxiety, reduced stress coping ability or depressive-like behavior (Kraus et al., 2017; Martinowich and Lu, 2008).”
Epigenetic Modulation of Mood Disorders
T, A. (2013) · Journal of Genetic Syndromes & Gene Therapy · doi:10.4172/2157-7412.1000120 · Cited by 51
“The secretion of BDNF is activity-dependent with reduced secretion linked to the effects of stress and mood disorders [182,183]; AD treatments generally elevate BDNF secretion [184,185].”
BackgroundPotential neurochemical links between cholesterol and suicidal behavior
Cantarelli, M. D. G., Tramontina, A. C., Leite, M. C., & Gonçalves, C. (2014) · Psychiatry Research · doi:10.1016/j.psychres.2014.10.017 · Cited by 59
Lee, L., Tu, C., Chen, L., Shen, H.-D., Chao, H., Lin, M., & Hsieh, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0112766 · Cited by 58
“and dopaminergic systems) are most likely involved [67–69].”
BackgroundToward an integration of cognitive and genetic models of risk for depression
Gibb, B. E., Beevers, C. G., & McGeary, J. E. (2013) · Cognition & Emotion · doi:10.1080/02699931.2012.712950 · Cited by 49
“However, since BDNF has been shown to modulate serotonergic neurons (Martinowich & Lu, 2008 ), it is unclear if the neurotrophic factors represent a unique aetiological pathway or are a critical component of the already identified serotonergic pathway.”
BackgroundGutiérrez, B., Bellón, J. Á., Rivera, M., Molina, E., King, M., Marston, L., Torres-González, F., Moreno-Küstner, B., Moreno-Peral, P., Motrico, E., et al. (2015) · Journal of Psychiatry and Neuroscience · doi:10.1503/jpn.140097 · Cited by 47
Drug withdrawal-induced depression: Serotonergic and plasticity changes in animal models
Renoir, T., Pang, T. Y., & Lanfumey, L. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2011.10.003 · Cited by 57
Schulte‐Herbrüggen, O., Fuchs, E., Abumaria, N., Ziegler, A., Danker‐Hopfe, H., Hiemke, C., & Hellweg, R. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22080 · Cited by 51
“A reciprocal interaction of the serotonergic system and BDNF has recently been reviewed (Martinowich and Lu, 2007).”
BackgroundMood disorders: A potential link between ghrelin and leptin on human body?
Zarouna, S., Wozniak, G., & Papachristou, A. I. (2015) · World Journal of Experimental Medicine · doi:10.5493/wjem.v5.i2.103 · Cited by 56
Sha, Q., Sun, B., Yi, C., Guan, R., Fei, J., Hu, Z., Liu, B., & Liu, X. (2019) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2019.05.060 · Cited by 56
Nagano, M., Liu, M., Inagaki, H., Kawada, T., & Suzuki, H. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.03.027 · Cited by 55
Imipramine and amitriptyline ameliorate the rotenone model of Parkinson’s disease in rats
Kandil, E. A., Abdelkader, N. F., El‐Sayeh, B. M., & Saleh, S. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.040 · Cited by 55
Chi, M. H., Chang, H. H., Lee, S.-Y., Lee, I. H., Gean, P. W., Yang, Y. K., Lu, R., & Chen, P. S. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.006 · Cited by 54
“Among them, brain derived neurotrophic factor (BDNF) was brought to light (Kozisek et al., 2008; Martinowich and Lu, 2008; Martinowich et al., 2007; Tsai et al., 2008).”
Schenkel, L. C., Segal, J., Becker, J. A., Manfro, G. G., Bianchin, M. M., & Leistner-Segal, S. (2010) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2010.04.023 · Cited by 53
“Recent evidence suggests that BDNF and serotonin systems interact to regulate the neural circuits involved in affective behaviors (Martinowich and Lu, 2008).”
BackgroundFocus on: neurotransmitter systems.
(2011) · Europe PMC (PubMed Central) · Cited by 53
Sarraf, P., Parohan, M., Javanbakht, M. H., Ranji‐Burachaloo, S., & Djalali, M. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.05.001 · Cited by 53
Dietary Fatty Acids and Microbiota-Brain Communication in Neuropsychiatric Diseases
Marrone, M. C., & Coccurello, R. (2019) · Biomolecules · doi:10.3390/biom10010012 · Cited by 45
“, via SSRIs administration) promotes neural and astrocyte BDNF expression [203].”
BackgroundPsychological and neurobiological aspects of suicide in adolescents: Current outlooks
Vargas‐Medrano, J., Diaz-Pacheco, V., Castaneda, C. A., Miranda-Arango, M., Longhurst, M. O., Martin, S. L., Ghumman, U., Mangadu, T., Chheda, S., Thompson, P. M., et al. (2020) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2020.100124 · Cited by 53
“In suicide victims, low levels of Brain-derived neurotrophic factor (BDNF) in the prefrontal cortex have been reported; impaired serotonin levels in this area can influence behaviors such as impulsivity, decision-making, and mood (Martinowich and Lu, 2008; Perroud et al., 2008).”
A neurobiological perspective on social influence: Serotonin and social adaptation
Duerler, P., Vollenweider, F. X., & Preller, K. H. (2022) · Journal of Neurochemistry · doi:10.1111/jnc.15607 · Cited by 53
“Therefore, 5- HT serves multiple roles in many lower- and higher- level functions including mood, emotion, sleep, appetite, reward and punishment learning, cooperation, decision- making and further homeostatic mechanisms (Jacobs & Azmitia, 1992; Martinowich & Lu, 2008; Roberts et al., 2020).”
BackgroundThe Problem of Malnutrition Associated with Major Depressive Disorder from a Sex-Gender Perspective
Montero, C. G., Ortega, M. A., Álvarez-Mon, M. Á., Fraile‐Μartinez, O., Romero-Bazán, A., Lahera, G., Montes, J. M. G., Molina-Ruiz, R. M., Mora, F., Rodríguez–Jiménez, R., et al. (2022) · Nutrients · doi:10.3390/nu14051107 · Cited by 53
Saggu, S., Pless, A., Dew, E., Ware, D., Jiao, K., & Wang, Q. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1543730 · Cited by 52
“Some medications can reduce proin fl ammatory cytokines like TNF-a and IL-6, further emphasizing the role of in fl ammation in MDD. Combining antidepressants with anti-in fl ammatory treatments may enhance therapeutic outcomes (210).”
InfluentialGlinert, A., Turjeman, S., Elliott, E., & Koren, O. (2021) · Biological reviews/Biological reviews of the Cambridge Philosophical Society · doi:10.1111/brv.12812 · Cited by 52
BDNF-TrkB signalling in fear learning: from genetics to neural networks
Musumeci, G., & Minichiello, L. (2011) · revneuro · doi:10.1515/rns.2011.031 · Cited by 51
“955 , 183 – 190. Yee, B.K., Zhu, S.W., Mohammed, A.H., and Feldon, J. (2007). Levels of neurotrophic factors in the hippocampus and amygdale correlate with anxiety- and fear-related behaviour in C57BL6 mice. J. Neural. Transm, 114 , 431 – 444. Yeo, G.S., Connie Hung, C.C., Rochford, J., Keogh, J., Gray, J., Sivaramakr…”
BackgroundSoga, T., Teo, C. H., & Parhar, I. S. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2020.601868 · Cited by 51
El-Marasy, S. A., El Awdan, S. A., Hassan, A., Ahmed-Farid, O. A., & Ogaly, H. A. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2020.109329 · Cited by 50
Khalil, M. H. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312924 · Cited by 49
“The interaction between BDNF and serotonin towards neurogenesis and synaptic plasticity was discussed by [72].”
Dalton, E. D., Hammen, C. L., Najman, J. M., & Brennan, P. A. (2014) · Journal of Family Psychology · doi:10.1037/fam0000032 · Cited by 50
“Overall, the study supports cumulative effects of BDNF val66met and 5HTTLPR, and is consistent with prior research indicating biological connectedness between serotonin and BDNF (Duman & Monteggia 2006; Martinowich & Lu, 2008).”
BackgroundResultThe Effects of Biological Sex and Ovarian Hormones on Exercise-Induced Neuroplasticity
El-Sayes, J., Turco, C. V., Skelly, L. E., Nicolini, C., Fahnestock, M., Gibala, M. J., & Nelson, A. J. (2019) · Neuroscience · doi:10.1016/j.neuroscience.2019.04.054 · Cited by 41
D’Addario, C., Bellia, F., Benatti, B., Grancini, B. M., Vismara, M. E. M., Pucci, M., Carlo, V. D., Viganò, C. A., Galimberti, D., Fenoglio, C., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.04.006 · Cited by 49
AP-1 controls the p11-dependent antidepressant response
Chottekalapanda, R. U., Kalik, S., Gresack, J. E., Ayala, A., Gao, M., Wang, W., Meller, S. J., Aly, A., Schaefer, A., & Greengard, P. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-0767-8 · Cited by 49
Huang, Y., Wu, Y., Jia, X., Lin, J., Xiao, L.-F., Liu, D., & Liang, M. (2022) · Food & Function · doi:10.1039/d1fo02938j · Cited by 49
Kudryavtseva, N. N., Смагин, Д. А., Kovalenko, I. L., Galyamina, A. G., Vishnivetskaya, G. B., Babenko, V. N., & Orlov, Y. L. (2017) · Molecular Biology · doi:10.1134/s0026893317020133 · Cited by 49
“org/) provide information that some types of 5-HT receptors are involved in the regulation of the Creb1 pathway, which increases or decreases the transcription of certain genes, in particular of the gene that encodes the BDNF associated with neurotransmission, neurogenesis, and synaptic plasticity [30] and ensuring su…”
BackgroundDiverse Functions of Multiple Bdnf Transcripts Driven by Distinct Bdnf Promoters
You, H., & Lu, B. (2023) · Biomolecules · doi:10.3390/biom13040655 · Cited by 48
Self-citationGao, X., Wang, J., Yao, H., Cai, Y., & Cheng, R. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.04.002 · Cited by 48
Biomarkers for major depression and its delineation from neurodegenerative disorders
Schneider, B., Prvulovic, D., Oertel‐Knöchel, V., Knöchel, C., Reinke, B., Grexa, M., Weber, B., & Hampel, H. J. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2011.08.001 · Cited by 47
“Furthermore, a common feature of brainderived neutrophic factor and serotonin is their ability to regulate the development and plasticity of neural circuits involved in mood disorders (Martinowich and Lu, 2008).”
Récamier-Carballo, S., Estrada-Camarena, E. M., & López‐Rubalcava, C. (2017) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000324 · Cited by 47
“, 2007; Yu and Chen, 2011), whereas increased BDNF signaling is related to antidepressant-like effects (Martinowich and Lu, 2008; Yu and Chen, 2011).”
BackgroundNeurochemicals, Behaviours and Psychiatric Perspectives of Neurological Diseases
Choudhury, A., Sahu, T., Ramanujam, P. L., Banerjee, A. K., Chakraborty, I., Arun Kumar, R., & Arora, N. (2018) · Neuropsychiatry · doi:10.4172/neuropsychiatry.1000361 · Cited by 47
“The same neurotransmitter is involved in regular physiological processes such as maintaining appetite, regular movement of bowels and GI tract, and digestion [39-41].”
BackgroundHormesis: What it is and Why it Matters
Mattson, M. P., & Calabrese, E. J. (2009) · Humana Press eBooks · doi:10.1007/978-1-60761-495-1_1 · Cited by 47
“For example, therapeutic doses of antidepressants such as fluoxetine and paroxetine induce an adaptive stress response in neurons in the brain that results in stimulation of the expression of BDNF ( Martinowich and Lu, 2008 ).”
BackgroundBrain-Derived Neurotrophic Factor: The Neurotrophin Hypothesis of Psychopathology
Stein, D. J., Daniels, W. M. U., Savitz, J., & Harvey, B. H. (2008) · CNS Spectrums · doi:10.1017/s1092852900013997 · Cited by 37
Carlson, J. M., Cha, J., Harmon‐Jones, E., Mujica-Parodi, L. R., & Hajcak, G. (2013) · Cerebral Cortex · doi:10.1093/cercor/bht089 · Cited by 46
Šagud, M., Perković, M. N., Vuksan‐Ćusa, B., Maravić, A., Štrac, D. Š., Peleš, A. M., Živković, M., Kušević, Z., & Pivac, N. (2016) · Psychopharmacology · doi:10.1007/s00213-016-4364-0 · Cited by 46
D’Addario, C., Palazzo, M. C., Benatti, B., Grancini, B. M., Pucci, M., Francesco, A. D., Camuri, G., Galimberti, D., Fenoglio, C., Scarpini, E. A., et al. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.08.011 · Cited by 46
“Also synergies between serotonin and BDNF systems were suggested to contribute to the regulation of the development and plasticity of neural circuits involved in the pathophysiology of affective disorders (Martinowich and Lu, 2008).”
BackgroundMaffioletti, E., Zanardini, R., Gennarelli, M., & Bocchio‐Chiavetto, L. (2014) · BioTechniques · doi:10.2144/000114204 · Cited by 46
Ribeiro, D. E., Müller, H. K., Elfving, B., Eskelund, A., Joca, S. R., & Wegener, G. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881119872173 · Cited by 45
Xu, M., Li, S., Xing, Q., Gao, R., Feng, G., Lin, Z., Clair, D. S., & He, L. (2010) · European Journal of Human Genetics · doi:10.1038/ejhg.2009.238 · Cited by 45
Plasminogen Activator Inhibitor-1 in depression: Results from Animal and Clinical Studies
Jiang, H., Li, X., Chen, S., Lu, N., Yue, Y., Liang, J., Zhang, Z., & Yuan, Y. (2016) · Scientific Reports · doi:10.1038/srep30464 · Cited by 41
Childhood maltreatment and stress-related psychopathology: the epigenetic memory hypothesis
Lutz, P.-E., Almeida, D., Fiori, L., & Turecki, G. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150105124928 · Cited by 44
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
“Additionaly, it has been suggested that stress-induced low transcription rates of BDNF can be reversed by SSRIs (Duman & Monteggia, 2006; Martinowich & Lu, 2008).”
BackgroundInfluentialHill, R. A., Murray, S. S., Halley, P. G., Binder, M. D., Martin, S. J., & van den Buuse, M. (2011) · Hippocampus · doi:10.1002/hipo.20759 · Cited by 41
“binding, BDNF-TrkB activation triggers a number of intracellular signaling pathways, including MAP kinase or ERK kinase-mitogen-activated protein kinase (MEK-MAPK), phosphatidylinositol-3-kinase (PI-3K), and phospholipase C-g (PLC-g) (Martinowich and Lu, 2008).”
BackgroundInfluentialCodella, R., Terruzzi, I., & Luzi, L. (2016) · Journal of Affective Disorders · doi:10.1016/j.jad.2016.10.035 · Cited by 44
“BDNF serum levels were found critically diminished in mood disorders (Martinowich and Lu, 2008), depression, schizophrenia (Lu and Martinowich, 2008) and in people under great psychological stress (Knaepen et al., 2010; Marosi and Mattson, 2014).”
BackgroundRègue, M., Poilbout, C., Martin, V., Franc, B., Lanfumey, L., & Mongeau, R. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0431-8 · Cited by 39
Sahu, M. P., Pazos-Boubeta, Y., Pajanoja, C., Rozov, S. V., Panula, P., & Ċastrén, E. (2019) · Scientific Reports · doi:10.1038/s41598-019-39347-3 · Cited by 44
The therapeutic potential of exercise for neuropsychiatric diseases: A review
Swenson, S., Blum, K., McLaughlin, T., Gold, M. S., & Thanos, P. K. (2020) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2020.116763 · Cited by 44
Antidepressant and Anti-Neuroinflammatory Effects of Bangpungtongsung-San
Park, B.-K., Kim, N. S., Kim, Y. R., Yang, C., Jung, I. C., Jang, I., Seo, C., Choi, J. J., & Lee, M. Y. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.00958 · Cited by 44
“Serotonin levels in the brain, an indicator of mood disorders (Martinowich and Lu, 2008), were significantly decreased in reserpine-treated mice, but oral BTS and FXT administration reversed this decrease (Figure 2A).”
BackgroundGomes, J. I., Farinha‐Ferreira, M., Rei, N., Gonçalves‐Ribeiro, J., Ribeiro, J. A., Sebastião, A. M., & Vaz, S. H. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105363 · Cited by 44
“neuroinflammation [22,23], decreased neuro- and synaptogenesis [24–26], diminished brain-derived neurotrophic factor (BDNF) signaling [27,28], and impaired synaptic plasticity [29,30], among other numerous alterations.”
BackgroundNadal‐Gratacós, N., Alberto‐Silva, A. S., Rodríguez-Soler, M., Urquizu, E., Espinosa‐Velasco, M., Jäntsch, K., Holy, M., Batllori, X., Berzosa, X., Pubill, D., et al. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.749429 · Cited by 44
“, 2017), as well as selective 5HT reuptake inhibitors (SSRIs) used in antidepressant treatment and an enhanced bdnf gene expression (Martinowich and Lu, 2008; Arosio et al., 2021; Casarotto et al., 2021).”
BackgroundChakravarty, K., Gaur, S., Kumar, R., Jha, N. K., & Gupta, P. K. (2024) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-024-10328-x · Cited by 44
“…like serotonin, BDNF (brain-derived neurotrophic factor), GABA (gamma-amin-obutyric acid), and glutamate, which have significant functions in the regulation of mood, memory, cognitive processes, neural excitatory-inhibitory balance, and learning, might be controlled by psychobiotics [120, 121].”
The Local Defender and Functional Mediator: Gut Microbiome
Yang, H., & Duan, Z. (2018) · Digestion · doi:10.1159/000484687 · Cited by 43
Wilson, N., Robb, E., Gajwani, R., & Minnis, H. (2020) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2020.12.025 · Cited by 43
Hoyer, C., Kranaster, L., Sartorius, A., Hellweg, R., & Gass, P. (2012) · Neuropsychobiology · doi:10.1159/000335243 · Cited by 37
Batsikadze, G., Paulus, W., Grundey, J., Kuo, M., & Nitsche, M. A. (2014) · Cerebral Cortex · doi:10.1093/cercor/bhu126 · Cited by 42
“Global nicotine and serotonin enhancement has shown to affect BDNF (Nibuya et al. 1995; Kenny et al. 2000; Martinowich and Lu 2008; Andresen et al. 2009), BDNF levels also have shown to be significantly lower in smokers than those of non-smoking controls, which is assumed to be caused by long-term…”
BackgroundMethodInfluentialCurcumin as a putative antidepressant
Seo, H., Wang, S., Han, C., Lee, S.-J., Patkar, A. A., Masand, P. S., & Pae, C. (2015) · Expert Review of Neurotherapeutics · doi:10.1586/14737175.2015.1008457 · Cited by 43
“Neuronal plasticity is influenced by neurotrophic factors such as brain-derived neurotrophic factor (BDNF) [68].”
BackgroundInfluentialSaccharide Effects on Cognition and Well-Being in Middle-Aged Adults: A Randomized Controlled Trial
Best, T., Kemps, E., & Bryan, J. (2009) · Developmental Neuropsychology · doi:10.1080/87565640903325709 · Cited by 42
“Because the serotonergic system of the brain plays a regulatory role in the development and plasticity of neural circuits that are involved in mood states, such as anxiety and depression (Martinowich & Lu, 2008), it is plausible that saccharides may have an effect on psychological well-being.”
BackgroundCreed, M. C., Hamani, C., & Nóbrega, J. N. (2012) · Brain stimulation · doi:10.1016/j.brs.2012.09.012 · Cited by 41
“Although the interaction between serotonin and BDNF is not fully understood, it has been reported that serotonin enhances BDNF gene expression [60].”
Dahiya, D., & Nigam, P. S. (2022) · Microorganisms · doi:10.3390/microorganisms10091687 · Cited by 40
Serotonin transporter gene moderates associations between mood, memory and hippocampal volume
Price, J. S., Strong, J. A., Eliassen, J. C., McQueeny, T. M., Miller, M. M., Padula, C. B., Shear, P. K., & Lisdahl, K. M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.11.013 · Cited by 40
Mouse Models of Polyglutamine Diseases in Therapeutic Approaches: Review and Data Table. Part II
Switonski, P. M., Szlachcic, W. J., Gabka, A., Krzyżosiak, W. J., & Figiel, M. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8316-3 · Cited by 42
“Serotonin triggers signaling cascade that lead to neurite outgrowth, synaptogenesis, neurogenesis and cell survival, and BDNF can promote the development and function of serotonergic neurons [100].”
BackgroundKetamine for post-traumatic stress disorders and it's possible therapeutic mechanism
Asim, M., Wang, B., Hao, B., & Wang, X. (2021) · Neurochemistry International · doi:10.1016/j.neuint.2021.105044 · Cited by 37
Millard, S. J., Lum, J. S., Fernandez, F., Weston–Green, K., & Newell, K. A. (2019) · Journal of Psychopharmacology · doi:10.1177/0269881118822141 · Cited by 41
Li, H., Guo, X., Li, P., Gao, X., Song, X., Chen, X., Liang, R., Yang, J., Li, Y., Chen, H., et al. (2024) · Environment International · doi:10.1016/j.envint.2024.108883 · Cited by 39
Park, S. H., Jang, S., Lee, S. W., Park, S., Sung, Y.-Y., & Kim, H. K. (2018) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2018.04.010 · Cited by 39
Burstein, O., Franko, M., Gale, E., Handelsman, A., Barak, S., Motsan, S., Shamir, A., Toledano, R., Simhon, O., Hirshler, Y., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188043 · Cited by 40
Balta, I., Butucel, E., Mohylyuk, V., Criste, A. D., Dezmirean, D. S., Ştef, L., Peț, I., & Corcionivoschi, N. (2021) · Diseases · doi:10.3390/diseases9030060 · Cited by 39
Psychobiotic Therapy: Method to Reinforce the Immune System
Magalhães‐Guedes, K. T. (2022) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2022.20.1.17 · Cited by 39
“Psychobiotic microorganisms can regulate brain pathways and serotonin production (mood controller) [11].”
BackgroundKim, H., Kim, H., Suh, H. J., & Choi, H. (2024) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.3c07260 · Cited by 39
Alterations to Embryonic Serotonin Change Aggression and Fearfulness
Dennis, R. L., Fahey, A. G., & Cheng, H. W. (2013) · Aggressive Behavior · doi:10.1002/ab.21459 · Cited by 39
“Serotonin has also been shown to have a strong relationship with brain derived neurotrophic factor (BDNF), two distinctly different systems that can interact or work synergistically to alter development, neurogenesis and plasticity [Martinowich and Lu, 2008].”
BackgroundGottfried, C., Bambini-Júnior, V., Baronio, D., Zanatta, G., Bristot, R., Vaccaro, T. D. S., & Riesgo, R. D. S. (2013) · InTech eBooks · doi:10.5772/54824 · Cited by 41
Wang, L., Ashley‐Koch, A., Steffens, D. C., Krishnan, K. R. R., & Taylor, W. D. (2012) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2012.00764.x · Cited by 36
Emanuel Miller Lecture: Early onset depressions – meanings, mechanisms and processes
Goodyer, I. M. (2008) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2008.01964.x · Cited by 34
“Interactions between BDNF and serotonin certainly occur biologically (Martinowich & Lu, 2007).”
BackgroundBhang, S., Ahn, J., & Choi, S. (2010) · Journal of Affective Disorders · doi:10.1016/j.jad.2010.07.008 · Cited by 40
“All rights reserved. and serotonergic neuron play an important role in regulating the development of depression (Martinowich and Lu, 2008).”
BackgroundTorres-Sánchez, S., Pérez-Caballero, L., & Berrocoso, E. (2016) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2016.09.005 · Cited by 40
“It is noteworthy that a close link has been described between serotonin and this neurotrophin (Martinowich & Lu, 2008).”
Brivio, P., Sbrini, G., Peeva, P., Todiraş, M., Bäder, M., Alenina, N. V., & Calabrese, F. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00389 · Cited by 39
“Indeed, it is well known that there is a correlation between 5-HT and BDNF (Martinowich and Lu, 2008), the main players in modulation of neurogenesis and neuroplastic mechanisms across lifespan (Homberg et al.”
BackgroundKim, E. Y., Choi, J.-E., Kim, M., Hong, J., & Park, Y. (2020) · Molecular Neurobiology · doi:10.1007/s12035-020-01980-9 · Cited by 38
Cong, W., Peng, Y., Meng, B., Jia, X., & Jin, Z. (2021) · Annals of Palliative Medicine · doi:10.21037/apm-20-1900 · Cited by 38
“BDNF and 5-HT play a key role in most depression, which may depend on their influence on neuronal plasticity and depression susceptibility (15,16).”
BackgroundAkkermansia muciniphila ameliorates depressive disorders in a murine alcohol-LPS (mALPS) model
Guo, D., Park, C., Li, Y., Li, B., Yang, Q., Deng, Y., Gao, N., Li, R., Wang, X., Yi, L., et al. (2022) · Food & Function · doi:10.1039/d2fo01478e · Cited by 38
Savas, S., Hyde, A. J., Stuckless, S. N., Parfrey, P. S., Younghusband, H. B., & Green, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038953 · Cited by 38
“Several studies, including those in BDNF-mutant mice, have suggested that alterations in expression or function of this gene are linked to anxiety, depression and post-traumatic disorder [12,13].”
BackgroundBiological underpinnings of an internalizing pathway to alcohol, cigarette, and marijuana use.
Trucco, E. M., Villafuerte, S. M., Hussong, A. M., Burmeister, M., & Zucker, R. A. (2018) · Journal of Abnormal Psychology · doi:10.1037/abn0000310 · Cited by 38
“BDNF is important in the regulation of neural circuits that are involved in depression (Martinowich & Lu, 2008).”
Background
Metadata
- Authors
- Martinowich, K., & Lu, B.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Lu, Bai
- Venue
- Neuropsychopharmacology
- Published
- 2007-09-19
- Volume
- 33
- Issue
- 1
- Pages
- 73-83
- ISSN
- 0893-133X (ISSN-L)
- 1740-634X
- OpenAlex
- W2067657652
- Cited by
- 793
- References
- 133
- Citations by year
- 2026: 34 · 2025: 42 · 2024: 48 · 2023: 38 · 2022: 58 · 2021: 67 · 2020: 52 · 2019: 54 · 2018: 44 · 2017: 43 · 2016: 40 · 2015: 39 · 2014: 36 · 2013: 36 · 2012: 43
- FWCI
- 2.90
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Neuropsychopharmacology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Nerve injury and regeneration
- Keywords
- brain-derived neurotrophic factor, serotonin, mood disorders, depression, anxiety, selective serotonin reuptake inhibitors, antidepressant effects, synaptic plasticity, neurogenesis, serotonergic neurons, serotonin transporter, genetic epistasis, emotional behavior
- MeSH terms
- Animals, Gene Expression Regulation, Humans, Neurons, Serotonin, Brain-Derived Neurotrophic Factor, Mood Disorders
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.